Multidrug resistance 1 (MDR1) 3435C/T genotyping in childhood drug-resistant epilepsy



      A mutation at nucleotide position 3435 in exon 26 of the multidrug resistance 1 (MDR1) gene is the most frequently studied polymorphism in relation to multidrug resistance. However, there are conflicting data as to whether the CC or TT genotype of the 3435C>T polymorphism is associated with drug resistance. Methods and results: We investigated the association between this polymorphism in drug-resistant childhood epilepsy by comparison with drug-responsive patients. In total, 59 patients with drug-resistant epilepsy, defined as having four or more seizures within a 12-month period while using three or more AEDs, 60 children with drug-responsive epilepsy who had remained seizure-free for 12 months on their current AED regimen and 76 healthy children were involved in this study. Genotype frequencies in drug-resistant patients were as follows: 32.2% CC, 44.1% CT, 23.7% TT; in the drug-responsive group: 20.0% CC, 50.0% CT, 30.0% TT; in the control group: 24.3% CC, 50.0% CT, 25.7% TT. Comparison of drug-resistant and drug-responsive patients revealed no significant difference in genotype frequency. The findings of the epilepsy patients were not significantly different from those of the healthy control subjects. Conclusions: Our study does not support any significant association between the MDR1 polymorphism and drug-resistant childhood epilepsy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Regesta G.
        • Tanganelli P.
        Clinical aspects and biological bases of drug-resistant epilepsies.
        Epilepsy Res. 1999; 34: 109-122
        • Ling V.
        Does P-glycoprotein predict response to chemotherapy?.
        J Natl Cancer Inst. 1989; 81: 84-85
        • Tishler D.M.
        • Weinberg K.I.
        • Hinton D.R.
        • Barbaro N.
        • Annett G.M.
        • Raffel C.
        MDR1 gene expression in brain of patients with medically intractable epilepsy.
        Epilepsia. 1995; 36: 1-6
        • Leschziner G.
        • Jorgensen A.L.
        • Andrew T.
        • Pirmohamed M.
        • Williamson P.R.
        • Marson A.G.
        • et al.
        Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study.
        Lancet Neurol. 2006; 5: 668-676
        • Sisodiya S.M.
        • Lin W.R.
        • Harding B.N.
        • Squier M.V.
        • Thom M.
        Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.
        Brain. 2002; 125: 22-31
        • Hegedus C.
        • Ozvegy-Laczka C.
        • Apáti A.
        • Magócsi M.
        • Német K.
        • Orfi L.
        • et al.
        Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties.
        Br J Pharmacol. 2009; 158: 1153-1164
        • Kim D.W.
        • Lee S.K.
        • Chu K.
        • Jang I.J.
        • Yu K.S.
        • Cho J.Y.
        • et al.
        Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.
        Epilepsy Res. 2009; 84: 86-90
        • Horinouchi M.
        • Sakaeda T.
        • Nakamura T.
        • Morita Y.
        • Tamura T.
        • Aoyama N.
        • et al.
        Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin.
        Pharm Res. 2002; 19: 1581-1585
        • Siddiqui A.
        • Kerb R.
        • Weale M.E.
        • Brinkmann U.
        • Smith A.
        • Goldstein D.B.
        • et al.
        Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.
        N Engl J Med. 2003; 348: 1442-1448
        • Sánchez M.B.
        • Herranz J.L.
        • Leno C.
        • Arteaga R.
        • Oterino A.
        • Valdizán E.M.
        • et al.
        Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
        Seizure. 2010; 19: 93-101
        • Proposal for revised classification of epilepsies and epileptic syndromes
        Commission on classification and terminology of the international league against epilepsy.
        Epilepsia. 1989; 30: 389-399
        • Commission on classification and terminology of the international league against epilepsy
        Proposal for revised clinical and electroencephalographic classification of epileptic seizures.
        Epilepsia. 1981; 22: 489-501
        • French J.A.
        Refractory epilepsy: clinical overview.
        Epilepsia. 2007; 48: 3-7
        • Lazarowski A.
        • Czornyj L.
        • Lubienieki F.
        • Girardi E.
        • Vazquez S.
        • D’Giano C.
        ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
        Epilepsia. 2007; 48: 140-149
        • Szakács G.
        • Váradi A.
        • Ozvegy-Laczka C.
        • Sarkadi B.
        The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).
        Drug Discov Today. 2008; 13: 379-393
        • Löscher W.
        • Potschka H.
        Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
        J Pharmacol Exp Ther. 2002; 301: 7-14
        • Sills G.J.
        • Mohanraj R.
        • Butler E.
        • McCrindle S.
        • Collier L.
        • Wilson E.A.
        • et al.
        Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
        Epilepsia. 2005; 46: 643-647
        • Hoffmeyer S.
        • Burk O.
        • von Richter O.
        • Arnold H.P.
        • Brockmöller J.
        • Johne A.
        • et al.
        Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.
        Proc Natl Acad Sci USA. 2000; 97: 3473-3478
        • Kwan P.
        • Baum L.
        • Wong V.
        • Ng P.W.
        • Lui C.H.
        • Sin N.C.
        • et al.
        Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese.
        Epilepsy Behav. 2007; 11: 112-117
        • Seo T.
        • Ishitsu T.
        • Ueda N.
        • Nakada N.
        • Yurube K.
        • Ueda K.
        • et al.
        ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
        Pharmacogenomics. 2006; 7: 551-561
        • Das A.
        • Balan S.
        • Banerjee M.
        • Radhakrishnan K.
        Drug resistance in epilepsy and the ABCB1 gene: the clinical perspective.
        Indian J Hum Genet. 2011; 17: 12-21
        • Dericioglu N.
        • Babaoglu M.O.
        • Yasar U.
        • Bal I.B.
        • Bozkurt A.
        • Saygi S.
        Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene.
        Epilepsy Res. 2008; 80: 42-46
        • Ozgon G.O.
        • Bebek N.
        • Gul G.
        • Cine N.
        Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey.
        Eur Neurol. 2008; 59: 67-70
        • Alpman A.
        • Ozkinay F.
        • Tekgul H.
        • Gokben S.
        • Pehlivan S.
        • Schalling M.
        • et al.
        Multidrug resistance 1 (MDR1) gene polymorphisms in childhood drug-resistant epilepsy.
        J Child Neurol. 2010; 25: 1485-1490
        • Chen L.
        • Liu C.Q.
        • Hu Y.
        • Xiao Z.T.
        • Chen Y.
        • Liao J.X.
        Association of a polymorphism in MDR1 C3435T with response to antiepileptic drug treatment in ethic Han Chinese children with epilepsy.
        Zhongguo Dang Dai Er Ke Za Zhi. 2007; 9: 11-14
        • Von Stülpnagel C.
        • Plischke H.
        • Zill P.
        • Bäumel C.
        • Spiegel R.
        • Gruber R.
        • et al.
        Lack of association between MDR1 polymorphisms and pharmacoresistance to anticonvulsive drugs in patients with childhood-onset epilepsy.
        Epilepsia. 2009; 50: 1835-1837
        • Sisodiya S.
        • Soranzo N.
        • Wood N.W.
        • Goldstein D.B.
        Association of genetic loci: replication or not, that is the question.
        Neurology. 2005; 64: 1989
        • Gururaj A.
        • Sztriha L.
        • Hertecant J.
        • Eapen V.
        Clinical predictors of intractable childhood epilepsy.
        J Psychosom Res. 2006; 61: 343-347